Diaceutics PLC

Investor Overview

At Diaceutics we believe that every patient should have access to the right treatment at the right timeWe provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.

DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

Investor Factsheet

Download our latest Investor Factsheet outlining key details about the DXRX business model and the opportunities for the platform to deliver a real difference in a high growth market.

Why invest in Diaceutics?

Interim Report June 2021

Corporate Governance

Financial Calendar


Year End
31st Dec


Half Year End
30th Jun

Why invest in Diaceutics?

Interim Report June 2021

Have a question?

Corporate Governance

Investor Alerts

If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.